HSSD give statement on GcMAF

The Health and Social Services Department has made its position clear on the availability of GcMAF to islanders. The department has no view on the efficacy or otherwise of GcMAF or any products that contain GcMAF. That is a matter solely for those people who wish to take the product on which to satisfy themselves, and we strongly recommend that they seek the advice of their treating clinician.

MHRA advice to HSSD is that GcMAF originating from Immuno Biotech’s production site in Cambridgeshire poses a risk to public health. There was nothing said at the meeting last night that alters that position. If that company wishes to supply GcMAF to islanders then the onus is on them to satisfy the department that the products used and the processes employed meet the necessary regulatory standards.